comparemela.com

Latest Breaking News On - Hemophilia a - Page 8 : comparemela.com

There Is Much to Consider and Discuss in Previously Untreated Hemophilia

Treatment options have improved care, but also increased the need for patient education.

Joint Damage in Severe Hemophilia A: The Importance of Early Treatment

Pain May Predict Impaired Outcomes in Patients With Hemophilia and Ankle Hemarthropathy

Hemarthropathy in multiple joints is a common feature of more severe forms of hemophilia, with the ankle joint often being reported as the main site of pain.

Study Examines Changes in Hemophilia Prescribing Practices Since 1999

Specific dosing regimens of treatments prescribed by blood specialists have not been widely studied, despite the advent of newer hemophilia therapies, the researchers said.

Sanofi s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition

FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster Roche drug Hemlibra.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.